SCHEMBL28656783

SCHEMBL28656783

CCOC(=O)CCCCc1ccc(C(=O)NCc2ccc(F)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.60
PPARG P37231 3/20 0.60
LMNA P02545 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.50
CYP4Z1 Q86W10 1/20 0.50
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
POLB P06746 2/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPK14 Q16539 1/20 0.47
HPGD P15428 1/20 0.47
GAA P10253 1/20 0.47
MAPK1 P28482 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
TRPV1 Q8NER1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6330958 0.86 CYP4Z1 (0.59) LMNACYP4Z1CYP3A4HPGDGAA
SCHEMBL28663154 0.84 MAPK14 (0.65) EPHX2PPARGLMNANPC1RAB9A
SCHEMBL5871481 0.82 CYP4F2 (0.58) LMNACYP4Z1HPGDGAAMAPK1
SCHEMBL28651771 0.81 EPHX2 (0.64) EPHX2PPARGLMNACYP4Z1HPGD
SCHEMBL28643158 0.80 EPHX2 (0.66) EPHX2PPARGHPGD
SCHEMBL28926992 0.80 EPHX2 (0.62) EPHX2PPARGCYP4Z1GAAMAPK1
SCHEMBL14393711 0.79 LMNA (0.67) EPHX2PPARGLMNAL3MBTL1NPC1
SCHEMBL9671800 0.77 CYP4Z1 (0.65) PPARGCYP4Z1CYP3A4GAAMAPK1
SCHEMBL6077802 0.77 L3MBTL1 (0.77) EPHX2PPARGLMNAL3MBTL1POLB
SCHEMBL11982117 0.76 MAPT (0.60) EPHX2L3MBTL1CYP4Z1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026028-B Treatment of diabetes and metabolic syndrome with novel dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors 威斯康星州医药大学股份有限公司 2021-11-09 CN disclosed